The Development of a PBPK Model for Atomoxetine Using Levels in Plasma, Saliva and Brain Extracellular Fluid in Patients with Normal and Deteriorated Kidney Function - Alsmadi, MM; AL Eitan, NL; Idkaidek, MN; Alzoubi, HK. (CNS & Neurological Disorders – Drug Targets, vol, 2022)